DATATRAK International, Inc. Exhibits at CBI's 5th Annual Forum on CTMS
CLEVELAND, March 19, 2012 /PRNewswire / -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its attendance at CBI's 5th Annual Forum on Clinical Trial Management Systems (CTMS). DATATRAK will be demonstrating its new uCTMS product, which offers visibility and control of your pipeline.
DATATRAK's Thought Leader and Chief Technology Officer, Chris Wilke, will be present at the forum exhibiting DATATRAK's uCTMS. Stop by our booth if you are interested in learning about:
- How our uCTMS improves visibility for executive management and gives clinical operations teams more control of their pipeline
- Why our uCTMS is the most comprehensive unified Clinical Trial Management System in the cloud; taking you from the planning stages of the trial all the way to its completion from Concept to Cure
- Best Practices for Initial Implementation and End-User Training
The conference is being held on March 22nd 23rd at the DoubleTree Hotel Philadelphia Center City and focuses on increasing efficiencies for optimal study management. The forum is the industry's only opportunity for in-depth discussion regarding CTMS systems. For more information on the conference: www.cbireg.com
About DATATRAK
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 16, 2012 announcing its fourth quarter and full year results for 2011. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.